Making practical sense of clinical trial data in decreasing cardiovascularrisk

Clinical studies now affirm what epidemiologic evidence has long suggested- that a broad range of patients can benefit from lipid reduction, including those without overt coronary artery disease and only moderate lipid elevati ons. Together, these studies suggest that current goals for cholesterol red uction may not be sufficiently stringent to slow the epidemic of heart dise ase in this country and that aggressive lipid lowering may be just what the doctor should order. (C) 2001 by Excerpta Medica, Inc.